Torthaí cuardaigh - Nicholas Butowski
- 1 - 20 toradh as 74 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis) de réir Eduardo Rodriguez Almaraz, Nicholas Butowski
Foilsithe / Cruthaithe 2023Revisão -
2
Recent Advances in Therapy for Glioblastoma de réir Jennifer Clarke, Nicholas Butowski, Susan M. Chang
Foilsithe / Cruthaithe 2010Revisão -
3
Treatment options for recurrent high-grade gliomas de réir Harjus Birk, Seunggu J. Han, Nicholas Butowski
Foilsithe / Cruthaithe 2016Revisão -
4
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM] de réir David R. Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid Chehab, Nicholas Butowski
Foilsithe / Cruthaithe 2024Revisão -
5
Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma de réir Mei‐Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer Clarke, Michael D. Prados
Foilsithe / Cruthaithe 2011Artigo -
6
Mouse models of glioblastoma for the evaluation of novel therapeutic strategies de réir Alexander F. Haddad, Jacob S. Young, Dominic Amara, Mitchel S. Berger, David R. Raleigh, Manish K. Aghi, Nicholas Butowski
Foilsithe / Cruthaithe 2021Revisão -
7
-
8
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma de réir Seunggu J. Han, Caleb Rutledge, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael D. Prados, Jennie Taylor, Mitchel S. Berger, Nicholas Butowski
Foilsithe / Cruthaithe 2015Artigo -
9
Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma de réir Mario E. Lacouture, Mary E. Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong
Foilsithe / Cruthaithe 2014Artigo -
10
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma de réir Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer Clarke, Michael D. Prados, Shannon Chang, Mitchel S. Berger, Annissa DeSilva, Nicholas Butowski
Foilsithe / Cruthaithe 2014Artigo -
11
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma de réir Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados
Foilsithe / Cruthaithe 2014Artigo -
12
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma de réir Edward Pan, Jeffrey G. Supko, Thomas Kaley, Nicholas Butowski, Timothy F. Cloughesy, Jinkyu Jung, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Deric M. Park
Foilsithe / Cruthaithe 2016Artigo -
13
Quality of life in low-grade glioma patients receiving temozolomide de réir Raymond Liu, Karla Solheim, Mei‐Yin C. Polley, Kathleen R. Lamborn, Margaretta Page, Anne Fedoroff, Jane Rabbitt, Nicholas Butowski, Michael D. Prados, Susan M. Chang
Foilsithe / Cruthaithe 2008Artigo -
14
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 de réir Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim
Foilsithe / Cruthaithe 2022Artigo -
15
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) de réir Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski
Foilsithe / Cruthaithe 2014Artigo -
16
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) de réir Nicholas Butowski, Susan M. Chang, Larry Junck, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Tim Cloughesy, Kathleen R. Lamborn, Andres Μ. Salazar, Michael D. Prados
Foilsithe / Cruthaithe 2008Artigo -
17
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma de réir Kazim Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J. Martin, Mitchel S. Berger, Jennifer Clarke, Jennie Taylor, Nancy Ann Oberheim Bush, Annette M. Molinaro, Manish K. Aghi, Nicholas Butowski
Foilsithe / Cruthaithe 2025Artigo -
18
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1 de réir Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Eric Burton, Nicholas Butowski, Mary Malec, A. Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley
Foilsithe / Cruthaithe 2006Artigo -
19
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma de réir Susan M. Chang, Sarah J. Nelson, Scott R. VandenBerg, Soonmee Cha, Michael D. Prados, Nicholas Butowski, Michael McDermott, Andrew T. Parsa, Manish K. Aghi, Jennifer Clarke, Mitchel S. Berger
Foilsithe / Cruthaithe 2009Artigo -
20
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma de réir Jennie Taylor, Mili Parikh, Joanna J. Phillips, C. David James, Annette M. Molinaro, Nicholas Butowski, Jennifer Clarke, Nancy Ann Oberheim-Bush, Susan M. Chang, Mitchel S. Berger, Michael D. Prados
Foilsithe / Cruthaithe 2018Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Oncology
Cancer research
Chemotherapy
Glioma
Surgery
Radiation therapy
Clinical trial
Cancer
Temozolomide
Biology
Pathology
Gene
Glioblastoma
Phases of clinical research
Clinical endpoint
Confidence interval
Genetics
Gastroenterology
Hazard ratio
Adverse effect
Progression-free survival
Bevacizumab
Meningioma
Biochemistry
Environmental health
Population
Adjuvant
Astrocytoma